HK1204990A1 - Stable igg4 binding agent formulations igg4 - Google Patents

Stable igg4 binding agent formulations igg4

Info

Publication number
HK1204990A1
HK1204990A1 HK15105917.2A HK15105917A HK1204990A1 HK 1204990 A1 HK1204990 A1 HK 1204990A1 HK 15105917 A HK15105917 A HK 15105917A HK 1204990 A1 HK1204990 A1 HK 1204990A1
Authority
HK
Hong Kong
Prior art keywords
igg4
binding agent
stable
agent formulations
formulations
Prior art date
Application number
HK15105917.2A
Other languages
English (en)
Chinese (zh)
Inventor
Dirk Usener
Ahmed Youssef
Annika Hagendorf
Martina Kirsch
Sabrina Ruggeberg
Julia Schnieders
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/033881 external-priority patent/WO2013148686A2/en
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1204990A1 publication Critical patent/HK1204990A1/xx

Links

HK15105917.2A 2012-03-26 2015-06-22 Stable igg4 binding agent formulations igg4 HK1204990A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615539P 2012-03-26 2012-03-26
FR1351013 2013-02-06
PCT/US2013/033881 WO2013148686A2 (en) 2012-03-26 2013-03-26 Stable igg4 binding agent formulations

Publications (1)

Publication Number Publication Date
HK1204990A1 true HK1204990A1 (en) 2015-12-11

Family

ID=54834982

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105917.2A HK1204990A1 (en) 2012-03-26 2015-06-22 Stable igg4 binding agent formulations igg4

Country Status (4)

Country Link
JP (1) JP6820823B2 (ja)
ES (1) ES2702246T3 (ja)
HK (1) HK1204990A1 (ja)
PT (1) PT2830658T (ja)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033228A1 (en) * 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
NZ571757A (en) * 2006-04-21 2012-01-12 Novartis Ag Antagonist anti-CD40 antibody pharmaceutical compositions comprising arginine-HCl and a citrate or citric acid buffer
JP5209625B2 (ja) * 2006-08-28 2013-06-12 協和発酵キリン株式会社 アンタゴニストのヒトｌｉｇｈｔ特異的ヒトモノクローナル抗体
AU2008232902B2 (en) * 2007-03-30 2013-10-03 Medlmmune, Llc Antibody formulation
FI20075278A0 (fi) * 2007-04-20 2007-04-20 Biotie Therapies Corp Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet
PT2195023T (pt) * 2007-08-29 2018-06-08 Sanofi Sa Anticorpos anti-cxcr5 humanizados, seus derivados e suas utilizações
FR2942799B1 (fr) * 2009-03-06 2011-02-25 Lfb Biotechnologies Anticorps monoclonal anti-rhesus d
JO3417B1 (ar) * 2010-01-08 2019-10-20 Regeneron Pharma الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
WO2011147921A1 (en) * 2010-05-28 2011-12-01 Novo Nordisk A/S Stable multi-dose compositions comprising an antibody and a preservative

Also Published As

Publication number Publication date
JP6820823B2 (ja) 2021-01-27
ES2702246T3 (es) 2019-02-28
JP2018048174A (ja) 2018-03-29
PT2830658T (pt) 2018-12-28

Similar Documents

Publication Publication Date Title
IL286348A (en) Pharmaceutical preparations that include allopregnanolone
HK1211188A1 (en) Nicotine composition
IL235322A0 (en) Pesticides
SG11201404577XA (en) Bactericidal agent composition
ZA201500212B (en) Progesterone formulations
PL2830658T3 (pl) Stabilne formulacje środków wiążących lgG4
IL235585A0 (en) Substances that bind to ha, preparations containing them and their uses
PT2582761E (pt) Composições de agente ligante aquoso
EP2934482A4 (en) ADMINISTRATIVE FORMULATIONS
HK1216250A1 (zh) '- '-羥基-二氫麥角胺化合物及組合物
EP2883549A4 (en) ANTIMICROBIAL COMPOSITION WITH FILOBASIDIUM FOR SUPPRESSING MEDICAMENTS OBTAINED FROM A NATURAL SUBSTANCE
EP2891694A4 (en) ADHESIVE COMPOSITION
IL233824A (en) Compounds 1h - Indazole - 3 - Carboxamide, preparations containing them and their use
HK1206976A1 (en) Composition for agent for external use
SG11201406278PA (en) Pesticidal composition
HK1205679A1 (en) Nicotine formulation
PT2908835T (pt) Formulações estáveis
HK1209973A1 (en) Anthracycline formulations
ZA201503755B (en) Herbicide composition
EP2905011A4 (en) PERFUME COMPOSITION
GB201105162D0 (en) Improved deodorant formulations
EP2856873A4 (en) HERBICIDE COMPOSITION
EP2834635A4 (en) COMPOSITIONS WITH A HEPARINE ACCUMULATIVE AND METHOD THEREFOR
HK1204990A1 (en) Stable igg4 binding agent formulations igg4
IL234771B (en) Nicotine formulation